EFFICACY OF PEGCETACOPLAN IN PATIENTS WITH LOWER BASELINE PROTEINURIA: A SUBGROUP ANALYSIS FROM THE VALIANT TRIAL

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/439c4d093f79d49e396fa19d31272f53.pdf
EFFICACY OF PEGCETACOPLAN IN PATIENTS WITH LOWER BASELINE PROTEINURIA: A SUBGROUP ANALYSIS FROM THE VALIANT TRIAL

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Seung Hyeok
Han
Seung Hyeok Han hansh@yuhs.ac Yonsei University College of Medicine Yonsei University College of Medicine Seoul Korea (Republic of) *
Hee Gyung Kang Kanghg@snu.ac.kr National University College of Medicine 2Kidney Disease Center for Children and Adolescents Seoul Korea (Republic of) -
Nicholas Webb nicholas.webb@sobi.com Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Stockholm Sweden -
Johan Szamosi johan.szamosi@sobi.com Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Stockholm Sweden -
Regina Horneff regina.horneff@sobi.com Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Stockholm Sweden -
Katie Gordon katie.gordon@apellis.com Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Waltham United States -
Yiwei Zhang yiwei.zhang@apellis.com Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Waltham United States -
Eli Khankin eli.khankin@apellis.com Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Waltham United States -
Carla Nester carla-nester@uiowa.edu Stead Family Children’s Hospital Stead Family Children’s Hospital Iowa United States -
-
-
-
-
-
-